A phase I trial using patupilone (epothilone B) and concurrent radiotherapy for CNS malignancies

被引:0
|
作者
Fogh, S. E. [1 ]
Machtay, M. [1 ]
Werner-Wasik, M. [1 ]
Curran, W. [1 ]
Bonanni, R. [1 ]
Mallon, G. [1 ]
Axelrod, R. [1 ]
Andrews, D. [1 ]
Dicker, A. [1 ]
机构
[1] Thomas Jefferson Univ, Philadelphia, PA 19107 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e14504
引用
收藏
页数:1
相关论文
共 50 条
  • [1] A phase I trial of patupilone (Epothilone B) and concurrent radiotherapy for CNS malignancies
    Machtay, M.
    Curran, W. J.
    Werner-Wasik, M.
    Mallon, G.
    Axelrod, R.
    Andrews, D.
    Dicker, A. P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S244 - S245
  • [2] PHASE I TRIAL USING PATUPILONE (EPOTHILONE B) AND CONCURRENT RADIOTHERAPY FOR CENTRAL NERVOUS SYSTEM MALIGNANCIES
    Fogh, Shannon
    Machtay, Mitchell
    Werner-Wasik, Maria
    Curran, Walter J., Jr.
    Bonanni, Roseann
    Axelrod, Rita
    Andrews, David
    Dicker, Adam P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 77 (04): : 1009 - 1016
  • [3] A PHASE I TRIAL USING PATUPILONE (EPOTHILONE B) AND CONCURRENT
    Fogh, Shannon E.
    Machtay, Mitchell
    Werner-Wasik, Maria
    Curran, Walter
    Bonanni, Roseann
    Axelrod, Rita
    Andrews, David W.
    Dicker, Adam P.
    NEURO-ONCOLOGY, 2009, 11 (05) : 663 - 663
  • [4] A phase I and pharmacologic trial of weekly epothilone B in patients with advanced malignancies.
    Oza, A
    Zamek, RM
    Siu, L
    Locsin, SM
    Moore, M
    Chen, F
    Chen, TL
    Cohen, P
    Rothermel, J
    Rubin, E
    ANNALS OF ONCOLOGY, 2000, 11 : 133 - 133
  • [5] Patupilone (Epothilone B) for Recurrent Glioblastoma: Clinical Outcome and Translational Analysis of a Single-Institution Phase I/II Trial
    Oehler, Christoph
    Frei, Karl
    Rushing, Elisabeth J.
    McSheehy, Paul M. J.
    Weber, Dirk
    Allegrini, Peter R.
    Weniger, Dorothea
    Luetolf, Urs M.
    Knuth, Alexander
    Yonekawa, Yasuhiro
    Barath, Krisztina
    Broggini-Tenzer, Angela
    Pruschy, Martin
    Hofer, Silvia
    ONCOLOGY, 2012, 83 (01) : 1 - 9
  • [6] PHASE I TRIAL USING PROTEASOME INHIBITOR BORTEZOMIB AND CONCURRENT TEMOZOLOMIDE AND RADIOTHERAPY FOR CENTRAL NERVOUS SYSTEM MALIGNANCIES
    Kubicek, Gregory J.
    Werner-Wasik, Maria
    Machtay, Mitchell
    Mallon, Gayle
    Myers, Thomas
    Ramirez, Michael
    Andrews, David
    Curran, Walter J., Jr.
    Dicker, Adam P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 74 (02): : 433 - 439
  • [7] Effects of Patupilone on the Pharmacokinetics and Pharmacodynamics of Warfarin in Patients with Advanced Malignancies: A Phase I Clinical Trial
    Tsimberidou, Apostolia-Maria
    Takimoto, Chris H. M.
    Moulder, Stacy
    Uehara, Cynthia
    Mita, Monica
    Mita, Alain
    Urban, Patrick
    Tan, Eugene
    Wang, Yanfeng
    Vining, David
    Kurzrock, Razelle
    MOLECULAR CANCER THERAPEUTICS, 2011, 10 (01) : 209 - 217
  • [8] Phase I trial using the proteasome inhibitor bortezomib (velcade) and concurrent chemoradiotherapy for head and neck malignancies
    Fogh, S. E.
    Kubicek, G. J.
    Machtay, M.
    Axelrod, R.
    Anne, R.
    Mallon, G.
    Keane, W. M.
    Myers, T.
    Curran, W. J.
    Dicker, A. P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S376 - S377
  • [9] Phase I Trial Using the Proteasome Inhibitor Bortezomib and Concurrent Chemoradiotherapy for Head-and-Neck Malignancies
    Kubicek, Gregory J.
    Axelrod, Rita S.
    Machtay, Mitchell
    Ahn, Peter H.
    Anne, Pramila R.
    Fogh, Shannon
    Cognetti, David
    Myers, Thomas J.
    Curran, Walter J., Jr.
    Dicker, Adam P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 83 (04): : 1192 - 1197
  • [10] Phase I dose-escalating trial of KOS-862 (epothilone D) in patients with advanced malignancies
    Rosen, L
    Kabbinavar, F
    Rosen, P
    Hecht, JR
    Parson, M
    Cropp, G
    McDaid, H
    Han, J
    Johnson, R
    Hannah, A
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S41 - S41